CD82 and neoplasm: Further, KAI-1 expression was reduced in larger tumor size (T3/T4) when referred to smaller tumor size (T1/T2), which was found to be statistically significant and shows 1.9 folds down regulation in the mRNA level of KAI-1 in larger tumor size (T3/T4 group) (Figure 1).